Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 1.65 million. The enterprise value is -707,433.
| Market Cap | 1.65M |
| Enterprise Value | -707,433 |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.31 million shares outstanding. The number of shares has increased by 54.81% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 17.31M |
| Shares Change (YoY) | +54.81% |
| Shares Change (QoQ) | +35.43% |
| Owned by Insiders (%) | 37.99% |
| Owned by Institutions (%) | 3.22% |
| Float | 8.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.36 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.88 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -189.42 |
Financial Efficiency
Return on equity (ROE) is -94.29% and return on invested capital (ROIC) is -56.64%.
| Return on Equity (ROE) | -94.29% |
| Return on Assets (ROA) | -42.21% |
| Return on Invested Capital (ROIC) | -56.64% |
| Return on Capital Employed (ROCE) | -113.74% |
| Revenue Per Employee | 106,415 |
| Profits Per Employee | -36,638 |
| Employee Count | 94 |
| Asset Turnover | 1.95 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -93.63% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 760,637 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Syra Health had revenue of 8.09 million and -2.78 million in losses. Loss per share was -0.32.
| Revenue | 8.09M |
| Gross Profit | 1.94M |
| Operating Income | -2.79M |
| Pretax Income | -2.78M |
| Net Income | -2.78M |
| EBITDA | -2.74M |
| EBIT | -2.79M |
| Loss Per Share | -0.32 |
Balance Sheet
The company has 2.49 million in cash and 129,807 in debt, giving a net cash position of 2.36 million or 0.14 per share.
| Cash & Cash Equivalents | 2.49M |
| Total Debt | 129,807 |
| Net Cash | 2.36M |
| Net Cash Per Share | 0.14 |
| Equity (Book Value) | 2.46M |
| Book Value Per Share | 0.03 |
| Working Capital | 2.38M |
Cash Flow
In the last 12 months, operating cash flow was -1.97 million and capital expenditures -5,492, giving a free cash flow of -1.98 million.
| Operating Cash Flow | -1.97M |
| Capital Expenditures | -5,492 |
| Free Cash Flow | -1.98M |
| FCF Per Share | -0.11 |
Margins
Gross margin is 24.02%, with operating and profit margins of -34.55% and -34.43%.
| Gross Margin | 24.02% |
| Operating Margin | -34.55% |
| Pretax Margin | -34.43% |
| Profit Margin | -34.43% |
| EBITDA Margin | -33.85% |
| EBIT Margin | -34.55% |
| FCF Margin | n/a |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.81% |
| Shareholder Yield | -54.81% |
| Earnings Yield | -168.41% |
| FCF Yield | -119.67% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |